These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30413008)

  • 1. Antiproliferative Activity of Combined Biochanin A and Ginsenoside Rh₂ on MDA-MB-231 and MCF-7 Human Breast Cancer Cells.
    Ren G; Shi Z; Teng C; Yao Y
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30413008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside Rh2 Ameliorates Doxorubicin-Induced Senescence Bystander Effect in Breast Carcinoma Cell MDA-MB-231 and Normal Epithelial Cell MCF-10A.
    Hou JG; Jeon BM; Yun YJ; Cui CH; Kim SC
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel all-trans retinoid acid derivatives inhibits the migration of breast cancer cell lines MDA-MB-231 via myosin light chain kinase involving p38-MAPK pathway.
    Wang B; Yan Y; Zhou J; Zhou Q; Gui S; Wang Y
    Biomed Pharmacother; 2013 Jun; 67(5):357-62. PubMed ID: 23602051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genistein-induced apoptosis of human breast cancer MCF-7 cells involves calpain-caspase and apoptosis signaling kinase 1-p38 mitogen-activated protein kinase activation cascades.
    Shim HY; Park JH; Paik HD; Nah SY; Kim DS; Han YS
    Anticancer Drugs; 2007 Jul; 18(6):649-57. PubMed ID: 17762393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic Interactions of 5-Fluorouracil with Inhibitors of Protein Kinase CK2 Correlate with p38 MAPK Activation and FAK Inhibition in the Triple-Negative Breast Cancer Cell Line.
    Wińska P; Karatsai O; Staniszewska M; Koronkiewicz M; Chojnacki K; Rędowicz MJ
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key role of nuclear factor-κB in the cellular pharmacokinetics of adriamycin in MCF-7/Adr cells: the potential mechanism for synergy with 20(S)-ginsenoside Rh2.
    Zhang J; Lu M; Zhou F; Sun H; Hao G; Wu X; Wang G
    Drug Metab Dispos; 2012 Oct; 40(10):1900-8. PubMed ID: 22745335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic Effect of Bioactive Anticarcinogens from Soybean on Anti-Proliferative Activity in MDA-MB-231 and MCF-7 Human Breast Cancer Cells In Vitro.
    Zhu Y; Yao Y; Shi Z; Everaert N; Ren G
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29954123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
    Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
    Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2α-Hydroxyursolic Acid Inhibited Cell Proliferation and Induced Apoptosis in MDA-MB-231 Human Breast Cancer Cells through the p38/MAPK Signal Transduction Pathway.
    Jiang X; Li T; Liu RH
    J Agric Food Chem; 2016 Mar; 64(8):1806-16. PubMed ID: 26872218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A triterpenoid from wild bitter gourd inhibits breast cancer cells.
    Bai LY; Chiu CF; Chu PC; Lin WY; Chiu SJ; Weng JR
    Sci Rep; 2016 Mar; 6():22419. PubMed ID: 26926586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
    Hu M; Wang J; Chen P; Reilly RM
    Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytoestrogens induce apoptosis via extrinsic pathway, inhibiting nuclear factor-kappaB signaling in HER2-overexpressing breast cancer cells.
    Seo HS; Choi HS; Choi HS; Choi YK; Um JY; Choi I; Shin YC; Ko SG
    Anticancer Res; 2011 Oct; 31(10):3301-13. PubMed ID: 21965740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of recombinant human erythropoietin and doxorubicin in combination on the proliferation of MCF-7 and MDA-MB231 breast cancer cells.
    Radwan EM; Abdullah R; Al-Qubaisi MS; El Zowalaty ME; Naadja SE; Alitheen NB; Omar AR
    Mol Med Rep; 2016 May; 13(5):3945-52. PubMed ID: 26987078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular effect of styrene substituted biscoumarin caused cellular apoptosis and cell cycle arrest in human breast cancer cells.
    Perumalsamy H; Sankarapandian K; Kandaswamy N; Balusamy SR; Periyathambi D; Raveendiran N
    Int J Biochem Cell Biol; 2017 Nov; 92():104-114. PubMed ID: 28958615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy of theophylline reduces necrotic effect of berberine, induces cell cycle arrest and PARP, HMGB1, Bcl-2 family mediated apoptosis in MDA-MB-231 breast cancer cells.
    Hashemi-Niasari F; Rabbani-Chadegani A; Razmi M; Fallah S
    Biomed Pharmacother; 2018 Oct; 106():858-867. PubMed ID: 30119256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lapatinib sensitizes quiescent MDA-MB-231 breast cancer cells to doxorubicin by inhibiting the expression of multidrug resistance-associated protein-1.
    Kwon YS; Chun SY; Nam KS; Kim S
    Oncol Rep; 2015 Aug; 34(2):884-90. PubMed ID: 26063481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunomodulatory drug lenalidomide restores a vitamin D sensitive phenotype to the vitamin D resistant breast cancer cell line MDA-MB-231 through inhibition of BCL-2: potential for breast cancer therapeutics.
    Brosseau C; Colston K; Dalgleish AG; Galustian C
    Apoptosis; 2012 Feb; 17(2):164-73. PubMed ID: 22109882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
    Bhowmik T; Gomes A
    Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.